PATENT CLAIM ANALYSIS

Application Number: 16009751
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "161000"]

Abstract:
The present invention relates to a method of reducing or preventing the symptoms associated with the common cold. The method comprises administering to a subject an effective amount of a pharmaceutical composition before presenting with at least one symptom of the common cold. The pharmaceutical composition comprises a non-steroidal anti-inflammatory drug and a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, salts thereof, and combinations thereof.

Claim (Index 19):
The pharmaceutical composition of  claim 18  wherein the amount of naproxen sodium is about 110 mg to about 900 mg, and the amount of fexofenadine is about 25 mg to about 200 mg.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 94.0
- Lexical Diversity: 1.55102
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15074524', '14699676', '11172878', '10363430', '13503097']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7672098479289671
- 35 USC 102 Novelty (BERT): 0.5093920005287291
- Combined Prediction Score: 0.7414280631889433
- Mean Citation Score: 211.190474
- Max Citation Score: 239.92516
- Similarity Product: 150.4051113636756

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test